Metabolic Imaging in Prostate Cancer: Where We Are - Wikidata - thesis-toulmin - TriplyDB

Metabolic Imaging in Prostate Cancer: Where We Are

Metabolic Imaging in Prostate Cancer: Where We Are

http://www.wikidata.org/entity/Q28074429

about

Skeletal muscle metastasis from the most common carcinomas orthopedic surgeons deal with. A systematic review of the literature.Glucose Metabolism in the Progression of Prostate Cancer.Imaging Cancer Metabolism.Prostate imaging features that indicate benign or malignant pathology on biopsy

P2860

Q38602700-D0C7DB6E-7524-47E4-B557-C80769F1D629 Q39167169-3866BB32-F830-4C5B-951E-8490D95FA1C1 Q47117264-EF0980BF-EC92-4851-ADD2-E9873F01CF62 Q58562204-976106C3-787E-47FB-B8C3-BF0ADC9F311F

P2860

Metabolic Imaging in Prostate Cancer: Where We Are

http://www.wikidata.org/entity/Q28074429

description

2016 nî lūn-bûn

@nan

2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Metabolic Imaging in Prostate Cancer: Where We Are

@ast

Metabolic Imaging in Prostate Cancer: Where We Are

@en

Metabolic Imaging in Prostate Cancer: Where We Are

@nl

type

label

Metabolic Imaging in Prostate Cancer: Where We Are

@ast

Metabolic Imaging in Prostate Cancer: Where We Are

@en

Metabolic Imaging in Prostate Cancer: Where We Are

@nl

prefLabel

Metabolic Imaging in Prostate Cancer: Where We Are

@ast

Metabolic Imaging in Prostate Cancer: Where We Are

@en

Metabolic Imaging in Prostate Cancer: Where We Are

@nl

P1433

Q28074429-CAFADF2D-61FD-4603-BC72-9729AA63EA09

P1476

Q28074429-0A60E614-C7F4-4BF5-99CA-F64AAD550F5B

P2093

Q28074429-9BC107ED-715D-48FD-91E1-5ED6D396996E

Q28074429-E05E0180-D029-468A-9824-0082281BB6E4

Q28074429-F368A452-733C-4BA7-9B4D-9AA19EC15AD3

Q28074429-F9067DD1-CD51-4AEA-B152-81E214E42A8B

P2860

Q28074429-02F4618E-D40F-480A-A667-DB61C029BBF6

Q28074429-040D9BBA-A3B1-4A06-A3A1-C12636F113BE

Q28074429-0CF7E678-0FCE-4DA2-AF55-55A492F79C05

Q28074429-22398CE7-12A9-4D80-BF4E-5D14F1A8D104

Q28074429-281DF620-1708-40C5-8108-0B86FEBDCB50

Q28074429-2C187236-44F4-4A60-BCC6-E202341BC852

Q28074429-3522D5BD-1395-4A6F-BA87-CA89FF990442

Q28074429-390648BE-B78A-409D-9D9D-1CCB26C29140

Q28074429-3DCCB1C0-8CF8-4E92-89E4-514A3023EDA6

Q28074429-3FACEA52-0B3C-4186-B6D2-DD049AFCD34D

P304

Q28074429-C5ECF676-FFDF-48A3-A3FE-565EA750C61B

P31

Q28074429-CC9E7E58-60D8-4B61-B8AD-EF98EA9373A5

P3181

Q28074429-8D0B2C3B-3369-4546-AFC8-8364A5C1F5FE

P356

Q28074429-40FB636E-FC90-483E-ACC8-38428BDFB97E

P407

Q28074429-98437508-EBFE-41EF-AA0E-47FD2C378CB0

P478

Q28074429-03ECEBFB-4980-456F-8DF6-FDD42E6EDF6F

P50

Q28074429-8F2F6C81-3EF7-4C0A-A69D-0663804A0567

P577

Q28074429-15C15CA2-3EFE-45BE-867B-801000AED48C

P698

Q28074429-0DE73FA2-3B76-43F5-A58F-DAACBAF600E0

P932

Q28074429-961D7921-0802-4C2A-8731-AC6D40D5A298

P3181

P356

FONC.2016.00225

P1433

Frontiers in Oncology

P1476

Metabolic Imaging in Prostate Cancer: Where We Are

@en

P2093

Claudia Testa

http://www.w3.org/2001/XMLSchema#string

Cristian Pultrone

http://www.w3.org/2001/XMLSchema#string

Raffaele Lodi

http://www.w3.org/2001/XMLSchema#string

Riccardo Schiavina

http://www.w3.org/2001/XMLSchema#string

P2860

The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots

ESUR prostate MR guidelines 2012

Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR

PET/CT: form and function.

Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis.

Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation

The intermediary metabolism of the prostate: a key to understanding the pathogenesis and progression of prostate malignancy

Automated vs. manual pattern recognition of 3D (1)H MRSI data of patients with prostate cancer.

Metabolic imaging of patients with prostate cancer using hyperpolarized [1-¹³C]pyruvate

Conventional imaging and multiparametric magnetic resonance (MRI, MRS, DWI, MRP) in the diagnosis of prostate cancer.

P304

225

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2603123

http://www.w3.org/2001/XMLSchema#string

P356

10.3389/FONC.2016.00225

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27882307

http://www.w3.org/2001/XMLSchema#string

P932

5101200

http://www.w3.org/2001/XMLSchema#string